NCT03989297View on ClinicalTrials.gov

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

December 30, 2019

Conditions
Nasopharyngeal Carcinoma
Interventions
RADIATION

Radiation

Consecutive patients who were pathologically diagnosed with NPC and treated with radiation at the Kiang Wu Hospital.

Trial Locations (1)

999078

Kiang Wu Hospital, Macao

All Listed Sponsors
lead

Kiang Wu Hospital

OTHER

NCT03989297 - PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter